Recent Investment Analysts’ Ratings Updates for JAN (JAN)

Several brokerages have updated their recommendations and price targets on shares of JAN (NYSE: JAN) in the last few weeks:

• 9/17/2026 – JAN had its price target raised by Scotiabank from $31.00 to $33.00. They now have a “sector outperform” rating on the stock.
• 9/16/2026 – JAN is now covered by Compass Point. They set a “neutral” rating and a $37.00 price target on the stock.
• 9/16/2026 – JAN is now covered by Compass Point. They set a “neutral” rating and a $37.00 price target on the stock.
• 9/15/2026 – JAN is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $36.00 price target on the stock.
• 9/15/2026 – JAN is now covered by Jefferies Financial Group Inc.. They set a “buy” rating and a $36.00 price target on the stock.
• 9/10/2026 – JAN is now covered by Huntington. They set an “outperform” rating and a $36.00 price target on the stock.
• 9/2/2026 – JAN had its price target raised by Scotiabank from $30.00 to $31.00. They now have an “outperform” rating on the stock.
• 9/1/2026 – JAN had its price target raised by Wells Fargo & Company from $33.00 to $35.00. They now have an “overweight” rating on the stock.
• 8/31/2026 – JAN had its price target raised by Barclays PLC from $33.00 to $34.00. They now have an “overweight” rating on the stock.
• 8/18/2026 – JAN had its price target raised by Morgan Stanley from $28.00 to $31.00. They now have an “overweight” rating on the stock.
• 8/18/2026 – JAN had its price target raised by JPMorgan Chase & Co. from $30.00 to $34.00. They now have an “overweight” rating on the stock.
• 8/11/2026 – JAN was downgraded by Zacks Research from “strong-buy” to “hold”.
• 8/10/2026 – JAN had its price target raised by Royal Bank Of Canada from $30.00 to $34.00. They now have an “outperform” rating on the stock.
• 8/8/2026 – JAN was upgraded by Wall Street Zen from “sell” to “hold”.
• 8/6/2026 – JAN is now covered by Weiss Ratings. They set a “hold (c-)” rating on the stock.
• 8/6/2026 – JAN had its price target raised by Cantor Fitzgerald from $30.00 to $34.00. They now have an “overweight” rating on the stock.

JAN Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 29th. Investors of record on Friday, December 18th will be paid a $0.0475 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a c) annualized dividend and a yield of 1.9%.

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.